Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-16 Sale | 2025-10-20 4:11 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $18.83 | $453,761 | 587,162 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:41 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,500 | $18.16 | $226,943 | 355,475 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 6:00 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $18.88 | $466,936 | 925,927 (Direct) | View |
| 2025-10-09 Sale | 2025-10-10 5:23 pm | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 22,000 | $18.45 | $405,900 | 164,367 (Direct) | View |
| 2025-10-09 Sale | 2025-10-10 5:22 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $18.23 | $116,931 | 261,939 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 5:33 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $18.21 | $553,198 | 543,850 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 5:33 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 50,500 | $18.06 | $911,842 | 541,309 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 4:57 pm | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 33,807 | $14.75 | $498,653 | 101,423 (Direct) | View |
| 2025-09-15 Sale | 2025-09-17 5:01 pm | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $11.49 | $181,875 | 142,468 (Direct) | View |
| 2025-06-16 Sale | 2025-06-18 5:12 pm | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $10.43 | $165,096 | 158,297 (Direct) | View |
| 2025-03-14 Sale | 2025-03-18 6:35 pm | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 79,146 | $12.9 | $1,021,211 | 174,306 (Direct) | View |
| 2024-09-16 Purchase | 2024-09-18 6:02 pm | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,833,000 | $18 | $32,994,000 | 2,652,575 (Indirect) | View |
| 2024-09-17 Purchase | 2024-09-17 6:16 pm | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 70,000 | $18 | $1,260,000 | 897,587 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-16 Exercise | 2025-10-20 4:11 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $0 | 587,162 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 4:11 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $3.7898 | 587,162 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:41 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $0 | 355,475 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:41 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $3.7898 | 355,475 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 6:00 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $0 | 925,927 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 6:00 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $3.7898 | 925,927 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:23 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 22,000 | $0 | 164,367 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:23 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 22,000 | $3.7898 | 164,367 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:22 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $0 | 261,939 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:22 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $3.7898 | 261,939 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $0 | 543,850 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $3.7898 | 543,850 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 32,000 | $0 | 541,309 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 32,000 | $3.7898 | 541,309 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 4:57 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 33,807 | $9.2435 | 101,423 (Direct) | View |
| 2025-09-29 Exercise | 2025-10-01 4:57 pm | N/A 2034-08-13 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 33,807 | $0 | 101,423 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-17 5:01 pm | N/A 2033-12-14 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $0 | 142,468 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-17 5:01 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $5.45 | 142,468 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 5:12 pm | N/A 2033-12-10 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $0 | 158,297 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 5:12 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 15,829 | $5.45 | 158,297 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:37 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | Haviland Kate Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:34 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 23,746 | $0 | 23,746 (Indirect) | View |
| 2025-06-09 Option Award | 2025-06-10 4:31 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:30 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:29 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | LONBERG NILS Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:28 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | Robertson Scott M. Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:27 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | Simson Jake Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 4:26 pm | N/A 2035-06-09 | Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-18 6:35 pm | N/A 2033-12-14 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 78,966 | $0 | 174,306 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-18 6:35 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 79,146 | $5.45 | 174,306 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-18 6:02 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 52,477,415 | $0 | 2,652,575 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-18 5:02 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON Former 10% Owner | 20,081,619 | $0 | 1,960,425 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-18 11:54 am | N/A N/A | Bicara Therapeutics Inc. | BCAX | FIL Ltd See Remark 1 | 1,013,853 | $0 | 1,013,853 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-18 11:54 am | N/A N/A | Bicara Therapeutics Inc. | BCAX | FMR LLC See Remark 1 | 1,115,333 | $0 | 1,115,333 (Indirect) | View |
| 2024-09-17 Conversion | 2024-09-17 6:16 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 16,809,237 | $0 | 897,587 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-16 5:49 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 23,746 | $0 | 23,746 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-16 4:42 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | LONBERG NILS Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-16 4:41 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | Simson Jake Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-16 4:39 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Biocon Ltd Biocon Pharma Inc. 10% Owner | 55,398,284 | $0 | 1,080,775 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-16 4:38 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | Haviland Kate Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-16 4:35 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | Robertson Scott M. Director | 23,746 | $0 | 23,746 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-16 4:35 pm | N/A 2034-09-12 | Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner | 23,746 | $0 | 456,482 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-16 4:35 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner | 63,155,572 | $0 | 456,482 (Indirect) | View |
Ownership | 2024-09-12 9:27 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 5,122,993 (Indirect) | View |
Ownership | 2024-09-12 9:20 pm | N/A 2033-12-14 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 0 | $0 | 388,502 (Direct) | View |
Ownership | 2024-09-12 9:19 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 0 | $0 | 1,103,415 (Direct) | View |
Ownership | 2024-09-12 9:16 pm | N/A 2034-08-06 | Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director | 0 | $0 | 59,501 (Direct) | View |
Ownership | 2024-09-12 9:15 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 0 | $0 | 607,946 (Direct) | View |
Ownership | 2024-09-12 9:11 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner | 0 | $0 | 6,306,188 (Direct) | View |
Ownership | 2024-09-12 9:11 pm | N/A 2034-08-06 | Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director | 0 | $0 | 59,501 (Direct) | View |
Ownership | 2024-09-12 9:09 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 0 | $0 | 2,674,577 (Direct) | View |